Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Short term Debt (2017 - 2022)

Nephros has reported Short term Debt over the past 8 years, most recently at $71000.0 for Q4 2022.

  • Quarterly results put Short term Debt at $71000.0 for Q4 2022, down 71.37% from a year ago — trailing twelve months through Dec 2022 was $71000.0 (down 71.37% YoY), and the annual figure for FY2022 was $71000.0, down 71.37%.
  • Short term Debt for Q4 2022 was $71000.0 at Nephros, down from $141000.0 in the prior quarter.
  • Over the last five years, Short term Debt for NEPH hit a ceiling of $991000.0 in Q4 2018 and a floor of $71000.0 in Q4 2022.
  • Median Short term Debt over the past 5 years was $226500.0 (2020), compared with a mean of $258250.0.
  • Biggest five-year swings in Short term Debt: soared 75.94% in 2019 and later crashed 71.37% in 2022.
  • Nephros' Short term Debt stood at $991000.0 in 2018, then plummeted by 69.73% to $300000.0 in 2019, then fell by 23.67% to $229000.0 in 2020, then rose by 8.3% to $248000.0 in 2021, then crashed by 71.37% to $71000.0 in 2022.
  • The last three reported values for Short term Debt were $71000.0 (Q4 2022), $141000.0 (Q3 2022), and $210000.0 (Q2 2022) per Business Quant data.